BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Small Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2158.56 only $1079.28

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,032.38
      0.56%
      US Tech 100
      20,389.60
      0.88%
      Dow Jones
      44,910.65
      0.42%
      Brent Oil
      71.98
      -0.08%
      Bitcoin
      96,383.47
      -1.13%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. TransCode Therapeutics Inc (RNAZ)

      7. TransCode Therapeutics Inc (RNAZ) Financials

      TransCode Therapeutics Inc

      TransCode Therapeutics Inc (RNAZ)

      NASDAQ
      0.348
      0.0049
      (1.43%)
      Closed November 30 4:00PM
      Delayed by 15 minutes
      0.3402
      -0.0078
      (-2.24%)
      After Hours: 5:00PM
      Delayed by 15 minutes

      Statistics

      Annual Quarterly
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Return on Assets (%) -595.098-372.359-57.042-115.082-290.735
      Return on Equity (%) 109.369103.763-80.525-148.573-759.771
      Return on Invested Capital (%) 816.07199.045-64.577-157.877-814.172
      Operating Margin (%) N/A N/A N/A N/A N/A
      Net Profit Margin (%) N/A N/A N/A N/A N/A
      Book Value Per Share -0.145-0.4461.5810.250.082
      Earnings Per Share -0.079-0.307-0.53-1.354-0.923
      Cash Per Share 0.0270.1081.6140.3830.138
      Working Capital Per Share 0.0180.0561.5650.2340.048
      Operating Profit Per Share N/A N/A N/A N/A N/A
      EBIT Per Share -0.079-0.307-0.53-1.354-0.923
      EBITDA Per Share -0.079-0.307-0.53-1.354-0.923
      Free Cash Flow Per Share -0.079-0.307-0.514-1.353-0.927

      Liquidity Ratios

      Year End December 30 2023 20192020202120222023
      Current Ratio N/A N/A N/A N/A N/A
      Quick Ratio N/A N/A N/A N/A N/A
      Inventory Turnover (Days) N/A N/A N/A N/A N/A
      Shares Outstanding 7.64M7.64M12.91MN/AN/A

      Key Stats and Ratios

      Year End December 30 2023 Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Shares Outstanding 12.98MN/AN/AN/AN/AN/AN/AN/A
      Return on Assets (%) N/A N/A N/A N/A N/A N/A N/A N/A
      Return on Equity (%) N/A N/A N/A N/A N/A N/A N/A N/A
      Return on Invested Capital (%) N/A N/A N/A N/A N/A N/A N/A N/A
      Operating Margin (%) N/A N/A N/A N/A N/A N/A N/A N/A
      Net Profit Margin (%) N/A N/A N/A N/A N/A N/A N/A N/A
      Sales Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Book Value Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Earnings Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Cash Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Working Capital Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Operating Profit Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      EBIT Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      EBITDA Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Free Cash Flow Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
      Quick Ratio N/A N/A N/A N/A N/A N/A N/A N/A
      Inventory Turnover (Days) N/A N/A N/A N/A N/A N/A N/A N/A

      Key Stats and Ratios

      Market Cap 5.92M
      Price to Earnings Ratio -0.33
      Price to Sales Ratio 0
      Price to Cash Ratio 2.18
      Price to Book Ratio 3.68
      Dividend Yield -

      Share Statistics

      Shares Outstanding 17.27M
      Average Volume (1 week) 803.06k
      Average Volume (1 Month) 474.81k
      52 Week Change -96.34%
      52 Week High 18.664
      52 Week Low 0.216
      More Ratios Coming Soon!

      Your Recent History

      NASDAQ
      RNAZ
      TransCode Therapeutics
      TSXV
      ALTA
      Altamira Gold
      Delayed Upgrade Clock